Immunohistochemical studies of pulmonary large cell neuroendocrine carcinoma: A possible association between staining patterns with neuroendocrine markers and tumor response to chemotherapy

Journal of Thoracic and Cardiovascular Surgery

Volumn 145, Issue 3, 2013, Pages 839-846

  Tanaka, Yugo ^a   Ogawa, Hiroyuki ^a   Uchino, Kazuya ^a   Ohbayashi, Chiho ^a   Maniwa, Yoshimasa ^b   Nishio, Wataru ^b   Nakao, Atsunori ^c   Yoshimura, Masahiro ^a  

^a HYOGO CANCER CENTER   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CHROMOGRANIN A; CISPLATIN; DOCETAXEL; ETOPOSIDE; IRINOTECAN; NAVELBINE; NERVE CELL ADHESION MOLECULE; PACLITAXEL; SYNAPTOPHYSIN;

ADULT; AGED; ARTICLE; BRONCHOPLASTY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INDUCTION CHEMOTHERAPY; LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG CARCINOMA; LUNG LOBECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT RESPONSE; WEDGE RESECTION;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, LARGE CELL; CARCINOMA, NEUROENDOCRINE; CHROMOGRANIN A; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEURAL CELL ADHESION MOLECULES; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; SYNAPTOPHYSIN; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84873997383     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2012.03.036     Document Type: Article

References (25)

1. W.D. Travis, R.I. Linnoila, M.G. Tsokos, C.L. Hitchcock, G.B. Cutler Jr., and L. Nieman Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma: an ultrastructural, immunohistochemical, and flow cytometric study of 35 cases Am J Surg Pathol 15 1991 529 553
2. W.D. Travis, B. Corrin, and Y. Shimosato Histological typing of lung and pleural tumors World Health Organization International Histological Classification of Tumors 3rd ed. 1999 Springer-Verlag Berlin
3. W.A. Cooper, V.H. Thourani, A.A. Gal, R.B. Lee, K.A. Mansour, and J.I. Miller The surgical spectrum of pulmonary neuroendocrine neoplasms Chest 119 2001 14 18
4. A. Iyoda, K. Hiroshima, T. Toyozaki, Y. Haga, T. Fujisawa, and H. Ohwada Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology Cancer 91 2001 1992 2000
5. H. Takei, H. Asamura, A. Maeshima, K. Suzuki, H. Kondo, and T. Niki Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases J Thorac Cardiovasc Surg 124 2002 285 292
6. R.J. Battafarano, F.G. Fernandez, J. Ritter, B.F. Meyers, T.J. Guthrie, and J.D. Cooper Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer J Thorac Cardiovasc Surg 130 2005 166 172
7. H. Asamura, T. Kameya, Y. Matsuno, M. Noguchi, H. Tada, and Y. Ishikawa Neuroendocrine neoplasms of the lung: a prognostic spectrum J Clin Oncol 24 2006 70 76
8. A. Iyoda, K. Hiroshima, T. Toyozaki, Y. Haga, M. Baba, and T. Fujisawa Adjuvant chemotherapy for large cell carcinoma with neuroendocrine features Cancer 92 2001 1108 1112
9. A. Iyoda, K. Hiroshima, Y. Moriya, Y. Takiguchi, Y. Sekine, and K. Shibuya Prospective study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma Ann Thorac Surg 82 2006 1802 1807
10. H. Saji, M. Tsuboi, J. Matsubayashi, K. Miyajima, Y. Shimada, and K. Imai Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy Anticancer Drugs 21 2010 89 93
11. I.S. Sarkaria, A. Iyoda, M.S. Roh, G. Sica, D. Kuk, and C.S. Sima Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience Ann Thorac Surg 92 2011 1180 1186
12. L. Sobin, and C.H. Wittekind TNM classification of malignant tumours 6th ed. 2002 Wiley-Liss New York 99 103
13. D.G. Guinee Jr., N.F. Fishback, M.N. Koss, S.L. Abbondanzo, and W.D. Travis The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open-lung biopsies Am J Clin Pathol 102 1994 406 414
14. F. González-Aragoneses, N. Moreno-Mata, M. Cebollero-Presmanes, M. García-Yuste, M.A. Cañizares-Carretero, and L. Molins-López-Rodó Prognostic significance of synaptophysin in stage I of squamous carcinoma and adenocarcinoma of the lung Cancer 110 2007 1776 1781
15. A.S.Y. Leung, K. Cooper, and F.J.W.M. Leung Manual of Diagnostic Antibodies for Immunohistology 1999 Greenwich Medical Media London 307
16. J.R. Gosney, M.A. Gosney, M. Lye, and S.A. Butt Reliability of commercially available immsunocytochemical markers for identification of neuroendocrine differentiation in bronchoscopic biopsies of bronchial carcinoma Thorax 50 1995 116 120
17. D.N. Ionescu, D. Treaba, C.B. Gilks, S. Leung, D. Renouf, and J. Laskin Nonsmall cell lung carcinoma with neuroendocrine differentiation - an entity of no clinical or prognostic significance Am J Surg Pathol 31 2007 26 32
18. B.I. Gustafsson, M. Kidd, A. Chan, M.V. Malfertheiner, and I.M. Modlin Bronchopulmonary neuroendocrine tumors Cancer 113 2008 5 21
19. A. Faggiano, J.C. Sabourin, M. Ducreux, J. Lumbroso, P. Duvillard, and S. Leboulleux Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: diagnostic and prognostic features Cancer 110 2007 265 274
20. M. Harada, T. Yokose, J. Yoshida, Y. Nishiwaki, and K. Nagai Immunohistochemical neuroendocrine differentiation is an independent prognostic factor in surgically resected large cell carcinoma of the lung Lung Cancer 38 2002 177 184
21. M.B. Beasley, S. Lantuejoul, S. Abbondanzo, W.S. Chu, P.S. Hasleton, and W.D. Travis The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung Hum Pathol 34 2003 136 142
22. A.T. Turrisi III, K. Kim, R. Blum, W.T. Sause, R.B. Livingston, and R. Komaki Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide N Engl J Med 340 1999 265 271
23. W.D. Travis, W. Rush, D.B. Flieder, R. Falk, M.V. Fleming, and A.A. Gal Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid Am J Surg Pathol 22 1998 934 944
24. G. Rossi, A. Cavazza, A. Marchioni, L. Longo, M. Migaldi, and G. Sartori Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung J Clin Oncol 23 2005 8774 8785
25. V.W. Rusch, D.S. Klimstra, and E.S. Venkatraman Molecular markers help characterize neuroendocrine lung tumors Ann Thorac Surg 62 1996 798 809 710